Laser-capture micro-dissection and gene array analysis to identify new molecules implicated in the development of myeloma bone disease (English)
- New search for: Buckle*, C.
- New search for: Andersen, T.
- New search for: Delaisse, J. M.
- New search for: Vanderkerken, K.
- New search for: Croucher, P. I.
- New search for: Buckle*, C.
- New search for: Andersen, T.
- New search for: Delaisse, J. M.
- New search for: Vanderkerken, K.
- New search for: Croucher, P. I.
In:
BONE -NEW YORK-
;
48
, 1
;
S19
;
2011
-
ISSN:
- Article (Journal) / Print
-
Title:Laser-capture micro-dissection and gene array analysis to identify new molecules implicated in the development of myeloma bone disease
-
Contributors:Buckle*, C. ( author ) / Andersen, T. ( author ) / Delaisse, J. M. ( author ) / Vanderkerken, K. ( author ) / Croucher, P. I. ( author )
-
Published in:BONE -NEW YORK- ; 48, 1 ; S19
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2011-01-01
-
Size:S19
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.71
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.71 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 48, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
IBMS Elected Board of Directors 2010-2011| 2011
- 2
-
IBMS 2011 Corporate Partners| 2011
- 3
-
IBMS Membership Application| 2011
- 5
-
Foreword: Skeletal Complications of CancerSmith, M. R. / Martin, T. J. et al. | 2011
- 6
-
Advances in the biology of bone metastasis: How the skeleton affects tumor behaviorSterling, J. A. / Edwards, J. R. / Martin, T. J. / Mundy, G. R. et al. | 2011
- 16
-
Dysregulation of developmental pathways in bone metastasisSethi, N. / Kang, Y. et al. | 2011
- 23
-
TGF-b in cancer and bone: Implications for treatment of bone metastasesJuarez, P. / Guise, T. A. et al. | 2011
- 30
-
Metastatic bone disease: Role of transcription factors and future targetsPratap, J. / Lian, J. B. / Stein, G. S. et al. | 2011
- 37
-
Epithelial plasticity, cancer stem cells and bone metastasis formationvan der Pluijm, G. et al. | 2011
- 44
-
Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasisLynch, C. C. et al. | 2011
- 54
-
Integrins and bone metastasis: Integrating tumor cell and stromal cell interactionsSchneider, J. G. / Amend, S. R. / Weilbaecher, K. N. et al. | 2011
- 66
-
The bone remodeling environment is a factor in breast cancer bone metastasisOoi, L. L. / Zheng, Y. / Stalgis-Bilinski, K. / Dunstan, C. R. et al. | 2011
- 71
-
Bisphosphonates' antitumor activity: An unravelled side of a multifaceted drug classClezardin, P. et al. | 2011
- 80
-
Advances in management of bone disease in breast cancerWalkington, L. / Coleman, R. E. et al. | 2011
- 88
-
Treatment and prevention of bone complications from prostate cancerLee, R. J. / Saylor, P. J. / Smith, M. R. et al. | 2011
- 96
-
Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasisLipton, A. / Goessl, C. et al. | 2011
- 100
-
Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone painYoneda, T. / Hata, K. / Nakanishi, M. / Nagae, M. / Nagayama, T. / Wakabayashi, H. / Nishisho, T. / Sakurai, T. / Hiraga, T. et al. | 2011
- 106
-
Optical advances in skeletal imaging applied to bone metastasesSnoeks, T. J. / Khmelinskii, A. / Lelieveldt, B. P. / Kaijzel, E. L. / Lowik, C. W. et al. | 2011
- 115
-
Effects of the bone marrow microenvironment on hematopoietic malignancyAskmyr, M. / Quach, J. / Purton, L. E. et al. | 2011
- 121
-
Tumor-host cell interactions in the bone disease of myelomaFowler, J. A. / Edwards, C. M. / Croucher, P. I. et al. | 2011
- 129
-
TGF-b-related mechanisms of bone destruction in multiple myelomaMatsumoto, T. / Abe, M. et al. | 2011
- 135
-
Osteoblast function in myelomaRoodman, G. D. et al. | 2011
- 141
-
Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destructionJohnson, L. C. / Johnson, R. W. / Munoz, S. A. / Mundy, G. R. / Peterson, T. E. / Sterling, J. A. et al. | 2011
- 152
-
Neuroblastoma and bone metastases: Clinical significance and prognostic value of Dickkopf 1 plasma levelsGranchi, D. / Corrias, M. V. / Garaventa, A. / Baglio, S. R. / Cangemi, G. / Carlini, B. / Paolucci, P. / Giunti, A. / Baldini, N. et al. | 2011
- 160
-
Skeletal complications and survival in renal cancer patients with bone metastasesWoodward, E. / Jagdev, S. / McParland, L. / Clark, K. / Gregory, W. / Newsham, A. / Rogerson, S. / Hayward, K. / Selby, P. / Brown, J. et al. | 2011
- i
-
Editorial Board| 2011
- S4
-
Reactivation of EMT-inducing transcription factors and cancer developmentPuisieux, A. et al. | 2011
- S5
-
Molecular genetics and risk of metastasisLinn, S. C. et al. | 2011
- S6
-
Controversies in the use of bone targeted agents: Breast cancer preventionChlebowski, R. T. et al. | 2011
- S7
-
Bone marrow endothelial cells as active players in the pathobiology of multiple myelomaVanderkerken, K. / De Bruyne, E. / Menu, E. / Van Valckenborgh, E. / Van Camp, B. et al. | 2011
- S8
-
Targeting cancer invasion and metastasisFrame, M. / Serrels, B. / Serrels, A. / Canel, M. / Sandilands, E. / Welman, A. / Brunton, V. et al. | 2011
- S9
-
New therapies for cancer-induced bone disease: Preclinical perspectiveGuise, T. et al. | 2011
- S10
-
Osteoclast-dependent and -independent effects of RANKL inhibition on tumorigenesis and metastasisDougall, B. et al. | 2011
- S11
-
SRC inhibition as an approach to treating tumor-induced bone diseaseBoyce, B. F. et al. | 2011
- S13
-
Identification of plasma biomarkers that predict breast cancer bone metastasisWasham*, C. L. / Byrum, S. D. / Leitzel, K. / Lipton, A. / Suva, L. J. et al. | 2011
- S14
-
TGF-b promotion of GLI2 induced pthrp expression is independent of canonical hedgehog signalingJohnson*, R. W. / Nguyen, M. P. / Padalecki, S. / Grubbs, B. / Merkel, A. R. / Oyajobi, B. / Mundy, G. R. / Sterling, J. A. et al. | 2011
- S15
-
BMP2/7 heterodimeric proteins are potent antagonists of TGFbeta-induced signaling, invasiveness and bone metastasis via inhibition of cancer stem cellsBuijs, J. T. / van der Horst*, G. / van den Hoogen, C. / Petersen, M. / Cheung, H. / de Rooij, B. / Pelger, R. C. / van der Pluijm, G. et al. | 2011
- S16
-
Results of the Medical Research Council (MRC) Myeloma IX study: Effects of zoledronic acid (ZOL) on overall survival (OS) in patients with multiple myeloma (MM)Morgan*, G. J. / Davies, F. E. / Gregory, W. M. / Bell, S. E. / Szubert, A. J. / Navarro Coy, N. / Ashcroft, A. J. / Drayson, M. T. / Owen, R. G. / Jackson, G. H. et al. | 2011
- S18
-
Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myelomaBrown*, J. E. / Barrios, C. H. / Diel, I. J. / Facon, T. / Fizazi, K. / Ibrahim, T. / Saad, F. / Senecal, F. / Stemmer, S. M. / Stopeck, A. et al. | 2011
- S19
-
Halofuginone reduces bone metastases: TGF-b-dependent and independent effectsJuarez*, P. / Mohammad, K. / Mckenna, R. / Walton, H. / Niewolna, M. / Chirgwin, J. M. / Guise, T. A. et al. | 2011
- S20
-
Patients with bone metastases from solid tumours and poor prognostic features may gain survival benefits from zoledronic acidBody*, J. / Cook, R. / Costa, L. / Brown, J. / Terpos, E. / Saad, F. / Lipton, A. / Coleman, R. et al. | 2011
- S22
-
An observational prospective cohort study on the dose effect of zoledronic acid on urinary n-telopeptide levels in metastatic prostate cancerDrudge-Coates*, L. / Brown, C. / Sherwood, R. / Thompson, P. M. / Muir, G. H. et al. | 2011
- S23
-
Efficacy of zoledronic acid in patients with colorectal cancer metastatic to boneSantini*, D. / Loupakis, F. / Berardi, R. / Badalamenti, G. / Addeo, L. / Ortega, C. / Sabbatini, R. / Venditti, O. / Virzi, V. / Vincenzi, B. et al. | 2011
- S25
-
Expression of matrix metalloproteinase 1 (MMP1) and dickkopf-1 (DKK1) in bone metastatic tissue (BMT) and in serum of patients with bone metastases (BM) from different solid tumorsCosta, L. / Luis*, I. / Alho, I. / Fernandes, A. / Casimiro, S. / Lee, B. H. / Gangolli, E. A. / Motwani, M. / Wang, L. / Modur, V. et al. | 2011
- S27
-
Hypocalcemia in multiple myeloma secondary to unrecognised vitamin D deficiency: A case reportRamasamy*, I. et al. | 2011
- S28
-
Metastatic bone disease of the mandible - A case reportDrozdzowska*, B. / Raczkowska-Siostrzonek, A. / Koszowski, R. et al. | 2011
- S29
-
Gene expression in prostate cancer bone metastases in relation to expression of the androgen receptor and one of its constitutively active variantsHornberg*, E. / Bergh, A. / Widmark, A. / Antti, H. / Wikstrom, P. et al. | 2011
- S30
-
The addition of zoledronic acid to combination chemotherapy decreases circulating serum levels of vascular endothelial growth factor (VEGF) in early breast cancerWinter*, M. C. / Evans, A. / Holen, I. / Coleman, R. E. et al. | 2011
- S32
-
CCN3 impairs osteoblasts and stimulates osteoclast differentiation to favor breast cancer metastasis to boneAmir*, E. / Ouellet, V. / Mourskaia, A. / Tiedemann, K. / Fong, J. / Tran-Tanh, D. / Clemons, M. / Perbal, B. / Komorova, S. / Siegel, P. et al. | 2011
- S33
-
A study of the role of twist in migration and invasion of breast cancer cellsLi, S. / Kendall, S. E. / Raices, R. / Tran, C. / Liu, Z. / Covarrubias, M. / Leigh, V. K. / Flanagan, S. D. / Glackin*, C. A. et al. | 2011
- S34
-
RANKL silencing by siRNA improves therapeutic response of primary osteosarcoma to conventional chemotherapyRousseau, J. / Escriou, V. / Lamoureux, F. / Brion, R. / Battaglia, S. / Scherman, D. / Heymann, D. / Redini*, F. / Trichet, V. et al. | 2011
- S35
-
Influence of pre-treatment with bisphosphonate on the outcome of photodynamic therapy on breast cancer metastases in murine vertebraeAkens*, M. K. / Wise-Milestone, L. / Won, E. / Wilson, B. C. / Yee, A. J. / Whyne, C. M. et al. | 2011
- S36
-
The novel anti-resorptive agent reveromycin A ameliorates bone destruction and tumor growth in myelomaWatanabe*, K. / Abe, M. / Qu, C. / Kawatani, M. / Hiasa, M. / Nakano, A. / Harada, T. / Nakamura, S. / Miki, H. / Kagawa, K. et al. | 2011
- S37
-
Targeting TCF transcriptional activity rescues syndecan-2 expression and re-sensitizes human osteosarcoma cells and mouse bone tumours to doxorubicinDieudonne*, F. X. / Marion, A. / Marie, P. J. / Modrowski, D. et al. | 2011
- S38
-
Accelerated osteolytic metastasis in B16-inoculated mice pre-exposed to non-skeletal focal irradiation in the abdomenFu, Q. / Hennings, L. / Gaddy, D. / Corry, P. M. / Jia*, D. et al. | 2011
- S39
-
Interaction of autotaxin with breast cancer cell integrins might contribute to lysophosphatidic acid-mediated bone metastasesDavid, M. / Leblanc, R. / Deux, B. / Serre, C. M. / Ribeiro, J. / Clezardin, P. / Peyruchaud*, O. et al. | 2011
- S40
-
Changes in osteoblast and osteoclast number rely on direct contact with breast cancer cells - Evidence from a longitudinal study of bone metastasisBrown*, H. K. / Ottewell, P. D. / Evans, C. A. / Holen, I. et al. | 2011
- S41
-
CpG-ODN inhibits Smad-dependent BMP signaling; Effects on myeloma cell apoptosis and in vitro osteoblastogenesisNorgaard, N. / Holien, T. / Jonsson, S. / Hella, H. / Espevik, T. / Sundan, A. / Standal*, T. et al. | 2011
- S42
-
An exopolysaccharide produced by alteromonas infernus reduces lung metastasis and prolongs survival rate of osteosarcoma-bearing miceRuiz Velasco*, C. / Colliec-Jouault, S. / Sinquin, C. / Heymann, D. / Padrines, M. et al. | 2011
- S43
-
Inhibition of Dickkopf-1 (DKK-1) delays prostate cancer growth in vivo through induction of P21CIP-1Hall*, C. L. / Zhang, H. / Baile, S. / Kuhstoss, S. / Keller, E. T. et al. | 2011
- S45
-
The homing of prostate cancer to bone in vivo is modulated by Zoledronic acidReeves*, K. J. / Cecchini, M. G. / van der Pluijm, G. / Eaton, C. L. / Hamdy, F. C. / Brown, N. J. et al. | 2011
- S46
-
Spontaneous fusion between prostate cancer cells: A driver for development of tumor heterogeneity and growth in bonePesce*, G. / Glen, A. / Lippitt, J. / Fowles, A. / Rehman, I. / Eaton, C. L. et al. | 2011
- S47
-
Twist 1 expression in an osteotropic breast cancer cell line promotes bone metastasis formation in mouseCroset*, M. / Goehrig, D. / Bonnelye, E. / Ansieau, S. / Puisieux, A. / Clezardin, P. et al. | 2011
- S48
-
Inhibition of discoidin domain receptor-1 (DDR1) impairs tumor-induced osteoclastogenesis preventing bone metastatic homing and colonizationValencia*, K. / Zandueta, C. / Ormazabal, C. / Luis-Ravelo, D. / Anton, I. / Martinez, S. / Lecanda, F. et al. | 2011
- S49
-
A method to follow tumor growth and tumor induced bone loss simultaneously over time, in vivo, using whole body bioluminescence fluorescence imagingSnoeks*, T. J. / Khmelinskii, A. / Que, I. / Lelieveldt, B. / Kaijzel, E. L. / Lowik, C. W. et al. | 2011
- S50
-
Development of a targeted strategy for enrichment and detection of calcium-binding proteins as potential biomarkers for bone metastases in breast cancerWood*, S. L. / Westbrook, J. A. / Peng, J. / Selby, P. J. / Brown, J. E. et al. | 2011
- S51
-
Breast cancer cell epidermal growth factor receptor signaling and osteolysisNickerson*, N. K. / Gilmore, J. L. / Robling, A. / Foley, J. et al. | 2011
- S54
-
Immune interplay between osteolytic disease and bone metastasisMonteiro, A. C. / Salvador, P. / Terra Mercadante, A. C. / Alves, A. P. / Balduino, A. / Duarte, M. E. / Bonomo*, A. et al. | 2011
-
Role of macrophages in tumour progression and therapyLewis, C. E. et al. | 2011
-
Cell trafficking in multiple myelomaGhobrial, I. et al. | 2011
-
Involvement of acidic microenvironment in bone pain associated with cancer colonizationYoneda, T. / Nakanishi, M. / Nishisho, T. / Wakabayashi, H. / Hata, K. et al. | 2011
-
Lessons to be learned from osteosarcomaHeymann, D. et al. | 2011
-
Tumour-secreted lox mediates osteolytic bone metastases prior to metastatic tumour cell colonisationEvans, H. R. / Ab Latif, N. / Cox, T. R. / Bird, D. / Lang, G. / Erler, J. T. / Gartland*, A. et al. | 2011
-
Adjuvant effect of IV clodronate on delay of bone metastasis in high-risk prostate cancer patientsRodrigues^@?, P. / Hering, F. et al. | 2011
-
Relationship between serum N-telopeptide and bone alkaline phosphatase and their diagnostic value in patients with breast cancer and bone metastasesLumachi@?, F. / Camozzi, V. / Luisetto, G. / Orlando, R. / Basso, S. M. / Basso, U. / Cappelletti, P. et al. | 2011
-
Prospective clinical trial to evaluate the value of radiofrequence ablation and cement augmentation of spinal metastasesProschek, D. / Habermann, B. / Tonak, M. / Proschek, P. / Kurth*, A. A. et al. | 2011
-
Peripheral cannabinoid type 2 receptor regulates osteoclast formation, MDA-MB-231 breast cancer cell migration and bone marrow/tumour cell interaction via PI3 kinase/AKT and P38 pathwaysSophocleous*, A. / Mackintosh, A. / Landao-Bassonga, E. / Ralston, S. H. / Idris, A. I. et al. | 2011
-
Molecular beacon-guided surgical resection of primary spinal neoplasmsLiu*, T. W. / Akens, M. / Chen, J. / Wise-Milestone, L. / Wilson, B. C. / Zheng, G. et al. | 2011
-
The search for metastatic founder cells: Molecular analysis of disseminated tumour cells from bone marrow of cancer patientsKlein, C. A. et al. | 2011
-
Modeling the metastatic microenvironment in bone - A single niche for hematopoietic stem cells and cancer provided by skeletal progenitorsBianco, P. et al. | 2011
-
Human bone marrow-derived mesenchymal stem cell homing to orthotopic breast cancer tumors and promotion of bone metastasisReagan*, M. R. / Goldstein, R. / Rosenblatt, M. / Kaplan, D. L. et al. | 2011
-
First evidence for anti-tumour effects of doxorubicin and zoledronic acid from an immunocompetent mouse modelOttewell*, P. D. / Brown, H. / Evans, C. A. / Wind, N. S. / Brown, N. J. / Coleman, R. E. / Holen, I. et al. | 2011
-
The causal role of the BMP signalling antagonist noggin in suppressing bone formation in osteolytic bone metastasisSecondini*, C. / Wetterwald, A. / Schwaninger, R. / Thalmann, G. N. / Cecchini, M. G. et al. | 2011
-
Zoledronic acid induces IPP accumulation and release from human cancer cells, which activates Vg9Vd2 T cell-differentiation and migration in vitro and mediates Vg9Vd2 T cell-induced cancer cell death in vivoBenzaid*, I. / Monkkonen, H. / Stresing, V. / Bonnelye, E. / Green, J. / Monkkonen, J. / Clezardin, P. et al. | 2011
-
A new B Crosslaps(R) (CTX-I) assay on the IDS-ISYS automated analyserSeres*, Z. / Middlemist, S. / Dixon, C. / Laurie, D. / Barnes, A. K. / Garrity, M. et al. | 2011
-
Osteocyte-derived FGF23 activates EGR-1 signaling in prostate cancer cells: A new vicious cycle in bone metastasesFournier, P. / Edwards, D. / White, K. / Chirgwin*, J. M. et al. | 2011
-
High-dose antioxidants as potential anti-osteolytic and palliative therapies for breast cancer bone metastasisPfister, W. / Blick, T. / Kok, S. F. / Polekhina, G. / Waltham*, M. et al. | 2011
-
New anabolic approaches to treating myeloma bone diseaseRoodman, G. et al. | 2011
-
Targeting tumour-initiating cells with trail based combination therapy ensures complete and lasting eradication of multiple myeloma tumours in vivoVitovski*, S. / Chantry, A. D. / Lawson, M. A. / Croucher, P. I. et al. | 2011
-
Natural history of malignant bone disease in colorectal cancer: Final results of a large Italian ''bone metastases'' surveySantini*, D. / Barni, S. / Tampellini, M. / Silvestris, N. / Maiello, E. / Calipari, N. / Ibrahim, T. / Catalano, V. / Vincenzi, B. / Tonini, G. et al. | 2011
-
One year effect of anastrozole and risedronate on bone mineral density: First results from the IBIS-II bone sub-studySingh*, S. / Cuzick, J. / Blake, G. M. / Mesher, D. / Patel, R. / Truscott, J. / Coleman, R. / Howell, A. / Forbes, J. / Eastell, R. et al. | 2011
-
Comparing early intervention with zoledronic acid to no bisphosphonate (BP) therapy in patients with metastatic prostate cancer to bone: A study of the US Veterans Affairs (VA) populationWu*, E. Q. / Guo, A. / Shi, L. / Lu, M. / Yu, A. P. / Sharma, H. / Fan, C. P. / Velde, N. V. et al. | 2011
-
Activation of the osteopontin gene, a bone metastatic signature, by transcription factor ERG in prostatic cancer cellsFlajollet, S. / Tian, T. V. / Flourens, A. / Tomavo, N. / Bonnelye, E. / Leroy, X. / Duterque-Coquillaud*, M. et al. | 2011
-
Direct anti-cancer effect of oncostatin M on chondrosarcomaDavid, E. / Guihard, P. / Brounais, B. / Riet, A. / Charrier, C. / Battaglia, S. / Ponsolle, S. / Le Bot, R. / Richards, C. D. / Heymann, D. et al. | 2011
-
The Italian cross-sectional survey on the management of bone health in oncology: The ZETA study (On Behalf of ZETA Study Group)Bertoldo*, F. / Santini, D. / Cecchini, I. / Bartolussi, P. / Fregosi, S. et al. | 2011
-
Reduced risk of breast cancer in postmenopausal women with osteoporosis. Preliminary results in a high risk metropolitan area: A case-control studyLumachi*, F. / Tombolan, V. / Camozzi, V. / Luisetto, G. / Basso, S. M. / Brunello, A. / Basso, U. et al. | 2011
-
Identification of hydrogen sulfide releasing compounds as novel antiresorptive and antitumour agentsIdris*, A. I. / Frantzias, J. / Mollat, P. / Sparatore, A. / Del Soldato, P. / Ralston, S. H. et al. | 2011
-
GLPG0187 inhibits progression of established bone metastasis and achieves maximum efficacy when combined with standard-of-care metastatic breast cancer treatmentsClement-Lacroix, P. / Berrocal, E. / Heckmann, B. / Wigerinck, P. / Lorenzon, G. / Pujuguet*, P. et al. | 2011
-
The role of parathyroid hormone-related protein in giant cell tumour of boneCowan*, R. W. / Singh, G. / Ghert, M. et al. | 2011
-
Effect of VEGF inhibitor PF-00337219 and FAK/PYK2 inhibitor PF-562,271 on intratibial growth of breast cancer cells in nude rats and miceBagi*, C. M. / Pero, R. / Berryman, E. / Aupi, D. / Wilkie, D. / Andresen, C. J. et al. | 2011
-
Risk of osteonecrosis of the jaw and the use of bone targeted therapiesRuggiero, S. L. et al. | 2011
-
Experimental study of specific antitumor immunity induced by dendritic cell vaccine transfected with tumor cell total RNA in Ewing's sarcoma patientsSang*, H. X. / Wang, J. / Wang, L. / Wang, Z. / Lu, B. / Fan, Y. / Zhu, W. J. et al. | 2011
-
Exploiting the tear proteome for the diagnosis of breast cancerWasham, C. / Byrum, S. / Bhattacharyya, S. / Klimberg, V. S. / Suva*, L. J. et al. | 2011
-
Analysis of the various components of bone turnover in postmenopausal breast cancer patients with bone metastasesBertoldo*, F. / Pancheri, S. / Boldini, S. / Zenari, S. / Avesani, A. et al. | 2011
-
The role of pamidronate in palliative treatment for bone metastases in squamous cell carcinoma of head and neckRolski*, W. / Leppert, W. et al. | 2011
-
Breast carcinoma cells modulate main characteristics and functional properties of human bone marrow-derived mesenchymal stromal cells in a non-contact dependent mannerWobus*, M. / Dittrich, T. / Hofbauer, L. / Ehninger, G. / Bornhauser, M. et al. | 2011
-
TGFb target gene NEDD9 identified by gene profiling plays a critical role in breast cancer bone metastasisHata*, K. / Morita, Y. / Nakanishi, M. / Nishisyou, T. / Yoneda, T. et al. | 2011
-
Multiphoton imaging of individual myeloma cells in calvariae: Association of myeloma development with sites of bone turnoverWilliams*, A. J. / Lawson, M. A. / Alamer, O. / Hough, J. / Bos, T. / Vanderkerken, K. / Croucher, P. I. et al. | 2011
-
A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone diseaseAklilu*, M. / Hussain, A. / Evans, C. P. / Hannon, R. A. / Lipton, A. / Dimairo, M. / Yu, J. / Zobel, P. / Torti, F. M. / Finkelman, R. D. et al. | 2011
-
Bone mineral density and bone remodelling markers osteocalcin and alkaline phosphatase in patients with Stage IV breast cancerLumachi*, F. / Camozzi, V. / Luisetto, G. / Orlando, R. / Basso, S. M. / Brunello, A. / Basso, U. et al. | 2011
-
Rapid pain reduction following loading-dose ibandronate in bone metastasesKurth*, A. A. / Muller, A. / Habermann, B. / Eberhardt, C. et al. | 2011
-
The chemokine receptor CXCR7 is highly expressed in bone metastatic lesions of human prostate cancer and mediates tumor cell growth and invasiveness in preclinical modelsGravina, G. L. / Angelini, M. / Montironi, R. / Ventura, L. / Marampon, F. / Pratesi, G. / Tortoreto, M. / Tombolini, V. / Festuccia*, C. et al. | 2011
-
Camp-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destructionSon, J. / Lee, J. H. / Kim, H. N. / Ha, H. / Lee*, Z. H. et al. | 2011
-
Skeletal rigidity enhances TGF-B effects on cancer cell expression of osteolytic factorsRuppender, N. S. / Sterling*, J. A. / Martin, T. J. / Mundy, G. R. / Guelcher, S. A. et al. | 2011
-
The role of fibronectin originating from different sources on breast cancer metastasis development and bone remodelingvon Au, A. / Vasel, M. / Cecchini, M. / Nakchbandi*, I. A. et al. | 2011
-
Calcium metabolism in castration-resistant prostate cancer patients: Development of a quantitative urinary assay for extent of bone metastasisHillegonds*, D. J. / Pan, C. X. / Lara, P. N. et al. | 2011
-
Quiescent stem cells in intestinal homeostasis, inflammation, and cancerFodde, R. et al. | 2011
-
62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancerGnant*, M. / Mlineritsch, B. / Stoeger, H. / Luschin-Ebengreuth, G. / Poestlberger, S. / Steger, G. / Jakesz, R. / Singer, C. / Eidtmann, H. / Greil, R. et al. | 2011
-
A multicenter prospective study of the risk factors affecting bone mineral density in Korean patients with prostate cancerJung, S. I. / Kim, S. O. / Kang*, T. W. / Kwon, D. D. / Park, J. Y. / Cheon, J. / Lee, H. M. / Hong, S. J. / Choi, H. Y. / Ryu, S. B. et al. | 2011
-
Cathepsin K inhibitors for the treatment of bone metastasisLindstrom*, E. / Vrang, L. / Sedig, S. / Terelius, Y. / Sahlberg, B. L. / Wikstrom, K. / Samuelsson, B. / Chambers, T. / Grabowska, U. et al. | 2011
-
10th International Conference on Cancer Induced Bone Disease| 2011
-
Denosumab decreases proliferation in giant cell tumor of bone (GCTB)Roudier, M. / Blay*, J. Y. / Chawla, S. / Manivel, C. / Nelson, S. D. / Thomas, D. / Woody, L. / Soriano, R. / Jun, S. / Jacobs, I. et al. | 2011
-
First randomized trial comparing balloon kyphoplasty (BKP) to non-surgical management among cancer patients with vertebral compression fracturesBastian*, L. / Pflugmacher, R. / Berenson, J. R. / Jarzem, P. / Zonder, J. / Tillman, J. B. / Ashraf, T. / Vrionis, F. D. et al. | 2011
-
Denosumab versus zoledronic acid (ZA) for the treatment of bone metastases: An integrated analysis of results from 2 randomized, double-blind, phase 3 trialsLipton*, A. / Stopeck, A. / von Moos, R. / Henry, D. / Richardson, G. / Rodriguez, G. / Bourgeois, H. / Ke, C. / Jun, S. / Dansey, R. et al. | 2011
-
Glutamate release in bone metastasisSeidlitz*, E. P. / Sharma, M. K. / Singh, G. et al. | 2011
-
Towards biomarkers of bone-metastasis using cellular proteomicsWestbrook*, J. A. / Peng, J. / Cairns, D. A. / Ottewell, P. D. / Holen, I. / Coleman, R. E. / Selby, P. J. / Banks, R. E. / Brown, J. E. et al. | 2011
-
Controlled skeletal tissue ablation using novel navigational radio frequence ablation deviceKurth*, A. A. / Proschek, D. / Germain, A. / Poser, R. et al. | 2011
-
Combination vs single agent treatment: The effects of zoledronic acid+/-doxorubicin on breast tumour growth in bone prior to development of osteolytic bone diseaseBrown*, H. K. / Ottewell, P. D. / Evans, C. A. / Coleman, R. E. / Holen, I. et al. | 2011
-
New therapies for cancer induced bone disease: Clinical perspectiveVan Poznak, C. et al. | 2011
-
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE-BIG 01-04) for women with stage II/III breast cancerColeman, R. E. / Woodward*, E. J. / Brown, J. E. / Cameron, D. / Bell, R. / Dodwell, D. / Keane, M. / Gil, M. / Davies, C. / Burkinshaw, R. et al. | 2011
-
Osteolytic versus mixed osteolytic/osteoblastic vertebral metastasis: Comparison of bone structural and remodelling properties in two preclinical rat modelsWise-Milestone*, L. / Akens, M. K. / Thudi, N. K. / Rosol, T. J. / Grynpas, M. D. / Yee, A. / Wilson, B. / Whyne, C. M. et al. | 2011
-
A direct contact model system to study tumor cell-bone cell interactions in prostate cancer bone metastasesNordstrand*, A. / Wikstrom, P. / Lerner, U. H. / Widmark, A. et al. | 2011
-
Molecular characterization of the stromal response to osteoblastic bone metastasis by tissue-compartment specific transcriptional profilingOzdemir*, B. / Secondini, C. / Wetterwald, A. / Schwaninger, R. / Raffelsberger, W. / Poch, O. / Delorenzi, M. / van der Pluijm, G. / Thalmann, G. N. / Cecchini, M. G. et al. | 2011
-
RAP-661 treatment, an ALK3 (BMPRIA) antagonist, decreases rankl and regulates osteoclastogenesisSolban*, N. / Cornwall-Brady, M. / Kawamoto, Y. / Underwood, K. W. / Kumar, R. / Seehra, J. / Canalis, E. / Pearsall, R. S. et al. | 2011
-
Surgical resection of isolated breast cancer recurrence within the sternumCrighton*, J. / Hall, P. / Lord, S. / Perrin, T. / Dodwell, D. et al. | 2011
-
Bone health in breast cancer survivors following adjuvant bisphosphonate therapy: AZURE quantitative bone scan sub-studyWoodward*, E. J. / Brown, J. E. / Barnfield, M. C. / Taylor, J. / Blake, G. M. / Fogelman, I. / Turner, L. A. / Thorpe, H. / Dodwell, D. / Joffe, J. K. et al. | 2011
-
Osteoprotegerin inhibitits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL produced by tumor cellsPicarda, G. / Matous, E. / Hervouet, S. / Lamoureux, F. / Trichet, V. / Heymann, D. / Redini, F. et al. | 2011
-
Local treatment of mixed osteolytic/osteoblastic spinal metastases: Is photodynamic therapy effective?Wise-Milestone*, L. / Akens, M. K. / Thudi, N. K. / Rosol, T. J. / Grynpas, M. D. / Yee, A. / Wilson, B. / Whyne, C. M. et al. | 2011
-
Abnormal expression of calpain-6 due to endothelin-1/NFkB signalling contributes to cell survival and chemoresistance in osteosarcoma cellsMarion*, A. / Dieudonne, F. X. / Patino, A. / Lecanda, F. / Marie, P. J. / Modrowski, D. et al. | 2011
-
Examination of the mechanism(s) of cancer-induced bone pain in animal modelsUngard*, R. / Seidlitz, E. / De Ciantis, P. / Yashpal, K. / Henry, J. L. / Singh, G. et al. | 2011
-
Comparison of optical, radiography and micro-Computed Tomography imaging methods for the analysis of bone metastases in a murine modelTiwari*, S. / Schem, C. / Lorenzen, A. C. / Kayser, O. / Graeff, C. / Pena, J. / Marshall, R. P. / Jonat, W. / Gluer, C. C. et al. | 2011
-
MNNG-HOS osteosarcoma growth is enhanced by human fat and adipose-derived mesenchymal stem cells: Implication in reconstructive surgery following tumor treatmentBourdais, L. / Perrot, P. / Duteille, D. / Hervouet, S. / Chesneau, J. / Amiaud, J. / Picarda, G. / De Pigneux, G. / Redini, F. / Heymann*, D. et al. | 2011
-
10th International Conference on Cancer Induced Bone Disease, 22-25 September 2010, Sheffield, UK Abstracts| 2011
-
Challenges of research on circulating tumour cells in carcinoma patientsRiethdorf, S. / Pantel, K. et al. | 2011
-
Laser-capture micro-dissection and gene array analysis to identify new molecules implicated in the development of myeloma bone diseaseBuckle*, C. / Andersen, T. / Delaisse, J. M. / Vanderkerken, K. / Croucher, P. I. et al. | 2011
-
Can bone biopsies be used to confirm metastatic disease recurrence and receptor status in breast cancer patients?Amir*, E. / Miller, N. / Geddie, W. / Maung, H. / Freedman, O. C. / Oldfield, M. / Napolskikh, J. / Kassam, F. / Clemons, M. et al. | 2011
-
Mechanisms of osteoblast supression in multiple myeolmaKassen*, D. / Rabin, N. / Lath, D. / Croucher, P. I. / Yong, K. et al. | 2011
-
Artificial niches that direct stem cell fateLutolf, M. P. et al. | 2011
-
Cancer and the evolution of stem cell fatesAndrews, P. W. et al. | 2011
-
Denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer: Results from a phase 3 randomized trialBrown*, J. / Carducci, M. / Fizazi, K. / Smith, M. / Damiao, R. / Karsh, L. / Milecki, P. / Wang, H. / Dansey, R. / Goessl, C. et al. | 2011
-
The role of macrophage stimulating protein in metastasis of breast cancer to boneKretschmann*, K. / Waltz, S. E. / Welm, A. L. et al. | 2011
-
TIMP-3 up-regulation facilitates osteoclastogenesis and suppresses DC differentiation from monocytes in the bone marrow microenvironment in myelomaAbe*, M. / Hiasa, M. / Nakano, A. / Nakamura, S. / Miki, H. / Qu, C. / Watanabe, K. / Harada, T. / Kagawa, K. / Takeuchi, K. et al. | 2011
-
Novel application of aptamer selection (pheno-SELEX) to target the invasive phenotype successfully creates anti-metastatic aptamersShelley*, G. / Zhang, X. / Keller, J. / Keller, E. et al. | 2011
-
Probing the relationship between breast cancer stem cells and bone metastasisTan-Allen, K. / Gilmore, J. E. / Foley, J. et al. | 2011
-
The novel and selective insulin-like growth factor-1 receptor kinase inhibitor PQIP suppresses bone cell function and osteoclast-breast cancer cell cross-talk in vitroLogan*, J. G. / Landao-Bassonga, E. / Brunton, V. G. / Idris, A. I. et al. | 2011
-
Does differential expression of CD151 affect the ability of beast cancer cells to establish tumours in bone?Wind*, N. S. / Brown, H. / Ottewell, P. D. / Sadej, R. / Romanska, H. / Berditchevski, F. / Holen, I. et al. | 2011
-
Corning osteo assay surface for the study of bone resorptionFaruqi*, A. F. / Rao, H. / Causer, J. / Beltzer, J. et al. | 2011
-
Evaluation of a novel bone targeted aracytidine therapy in dogs with spontaneous osteosarcomaZinnen*, S. / Thamm, D. / Vail, D. / Fan, T. / Karpeisky, A. et al. | 2011
-
Improved methods for 3D SEM imaging of cancellous bone in metastatic cancers in boneBoyde*, A. / Harland, S. et al. | 2011
-
Prostate cancer-derived exosomes down-modulate NKG2D expression in immune effector cellsLundholm*, M. / Wikstrom, P. et al. | 2011